These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9721257)

  • 1. Trichloroethene levels in human blood and exhaled breath from controlled inhalation exposure.
    Pleil JD; Fisher JW; Lindstrom AB
    Environ Health Perspect; 1998 Sep; 106(9):573-80. PubMed ID: 9721257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exhaled human breath measurement method for assessing exposure to halogenated volatile organic compounds.
    Pleil JD; Lindstrom AB
    Clin Chem; 1997 May; 43(5):723-30. PubMed ID: 9166222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trichloroethylene [correction of Trichloroethene] levels in human blood and exhaled breath from controlled inhalation exposure.
    Wallace L
    Environ Health Perspect; 1998 Sep; 106(9):531-3. PubMed ID: 9841213
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of a physiologically based model to predict systemic uptake and respiratory elimination of perchloroethylene.
    Dallas CE; Muralidhara S; Chen XM; Ramanathan R; Varkonyi P; Gallo JM; Bruckner JV
    Toxicol Appl Pharmacol; 1994 Sep; 128(1):60-8. PubMed ID: 8079355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol.
    Fisher JW; Mahle D; Abbas R
    Toxicol Appl Pharmacol; 1998 Oct; 152(2):339-59. PubMed ID: 9853003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake and decay of volatile organic compounds at environmental concentrations: application of a four-compartment model to a chamber study of five human subjects.
    Wallace LA; Nelson WC; Pellizzari ED; Raymer JH
    J Expo Anal Environ Epidemiol; 1997; 7(2):141-63. PubMed ID: 9185009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiological pharmacokinetic modeling of inhaled trichloroethylene in rats.
    Dallas CE; Gallo JM; Ramanathan R; Muralidhara S; Bruckner JV
    Toxicol Appl Pharmacol; 1991 Sep; 110(2):303-14. PubMed ID: 1891776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the percutaneous absorption of trichloroethylene in rats and humans using MS/MS real-time breath analysis and physiologically based pharmacokinetic modeling.
    Poet TS; Corley RA; Thrall KD; Edwards JA; Tanojo H; Weitz KK; Hui X; Maibach HI; Wester RC
    Toxicol Sci; 2000 Jul; 56(1):61-72. PubMed ID: 10869454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body burden measurements and models to assess inhalation exposure to methyl tertiary butyl ether (MTBE).
    Buckley TJ; Prah JD; Ashley D; Zweidinger RA; Wallace LA
    J Air Waste Manag Assoc; 1997 Jul; 47(7):739-52. PubMed ID: 9248366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicokinetics of inhaled trichloroethylene and tetrachloroethylene in humans at 1 ppm: empirical results and comparisons with previous studies.
    Chiu WA; Micallef S; Monster AC; Bois FY
    Toxicol Sci; 2007 Jan; 95(1):23-36. PubMed ID: 17032701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A linear model relating breath concentrations to environmental exposures: application to a chamber study of four volunteers exposed to volatile organic chemicals.
    Wallace L; Pellizzari E; Gordon S
    J Expo Anal Environ Epidemiol; 1993; 3(1):75-102. PubMed ID: 8518547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of real-time breath analysis and physiologically based pharmacokinetic modeling to evaluate dermal absorption of aqueous toluene in human volunteers.
    Thrall KD; Weitz KK; Woodstock AD
    Toxicol Sci; 2002 Aug; 68(2):280-7. PubMed ID: 12151623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ingestion, inhalation, and dermal exposures to chloroform and trichloroethene from tap water.
    Weisel CP; Jo WK
    Environ Health Perspect; 1996 Jan; 104(1):48-51. PubMed ID: 8834861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologically based pharmacokinetic modeling of inhaled trichloroethylene and its oxidative metabolites in B6C3F1 mice.
    Greenberg MS; Burton GA; Fisher JW
    Toxicol Appl Pharmacol; 1999 Feb; 154(3):264-78. PubMed ID: 9931286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The uptake and elimination of 1,1,1-trichloroethane during and following inhalation exposures in rats.
    Dallas CE; Ramanathan R; Muralidhara S; Gallo JM; Bruckner JV
    Toxicol Appl Pharmacol; 1989 May; 98(3):385-97. PubMed ID: 2718170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled today, not gone tomorrow: pharmacokinetics and environmental exposure of volatiles in exhaled breath.
    Beauchamp J
    J Breath Res; 2011 Sep; 5(3):037103. PubMed ID: 21654021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermal, oral, and inhalation pharmacokinetics of methyl tertiary butyl ether (MTBE) in human volunteers.
    Prah J; Ashley D; Blount B; Case M; Leavens T; Pleil J; Cardinali F
    Toxicol Sci; 2004 Feb; 77(2):195-205. PubMed ID: 14600279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantitative study of the influence of inhaled compounds on their concentrations in exhaled breath.
    Spaněl P; Dryahina K; Smith D
    J Breath Res; 2013 Mar; 7(1):017106. PubMed ID: 23445832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining physiologically based pharmacokinetic modeling with Monte Carlo simulation to derive an acute inhalation guidance value for trichloroethylene.
    Simon TW
    Regul Toxicol Pharmacol; 1997 Dec; 26(3):257-70. PubMed ID: 9441916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A physiologically based pharmacokinetic model for inhaled carbon tetrachloride.
    Paustenbach DJ; Clewell HJ; Gargas ML; Andersen ME
    Toxicol Appl Pharmacol; 1988 Nov; 96(2):191-211. PubMed ID: 3143166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.